<?xml version="1.0" encoding="UTF-8"?>
<p>Also, during the treatment process, CT can be used to follow the disease time course and quickly detect lung complications. The number, range, and density of GGOs are reported to increase as the disease progresses [
 <xref rid="b29-medscimonit-26-e924582" ref-type="bibr">29</xref>,
 <xref rid="b34-medscimonit-26-e924582" ref-type="bibr">34</xref>], while smaller size, range, and absorption of GGOs or consolidation indicated improved disease condition [
 <xref rid="b35-medscimonit-26-e924582" ref-type="bibr">35</xref>, 
 <xref rid="b36-medscimonit-26-e924582" ref-type="bibr">36</xref>]. CT manifestations can be divided into early stage, advanced stage, critical stage, and involuted stage based on lesion extension and severity [
 <xref rid="b12-medscimonit-26-e924582" ref-type="bibr">12</xref>]. Pan et al. revealed that in early-stage disease, CT images in approximately 50% of patients had peripheral lung opacities. The GGOs developed rapidly, demonstrating crazy-paving and/or consolidation involving multiple lobes (
 <xref ref-type="fig" rid="f4-medscimonit-26-e924582">Figure 4</xref>). In patients without ARDS, chest CT showed that lesions were most severe about 10 days after the onset, which then began to improve [
 <xref rid="b37-medscimonit-26-e924582" ref-type="bibr">37</xref>]. A subset of patients whose CT imaging showed multiple lobular lesions or progression of lesion focus within 48 h â‰¥50% indicated critical stage and the need for Intensive Care Unit (ICU) monitoring and treatment [
 <xref rid="b38-medscimonit-26-e924582" ref-type="bibr">38</xref>].
</p>
